Publications by authors named "Anja Loos"

Claim this Profile
A
A connection between survival multistate models and causal inference for external treatment interruptions.
Alexandra Erdmann, Anja Loos, Jan Beyersmann

Stat Methods Med Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1.
Yulia Vugmeyster, Ana-Marija Grisic, Justin J Wilkins, Anja H Loos, Roland Hallwachs

Cancer Chemother Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.
Regina Stegherr, Claudia Schmoor, Jan Beyersmann, Kaspar Rufibach, Valentine Jehl, Anja Loos

Trials· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multistate modeling of clinical hold in randomized clinical trials.
Alexandra Nießl, Jan Beyersmann, Anja Loos

Pharm Stat· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the potential for QTc prolongation with avelumab.
Yulia Vugmeyster, Gülseren Güzel, Meliessa Hennessy, Anja H Loos, Haiqing Dai

Cancer Chemother Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies.
Steffen Unkel, Marjan Amiri, Norbert Benda, Jan Beyersmann, Dietrich Knoerzer, Anja Loos

Pharm Stat· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials.
Karen Kelly, Jeffrey R Infante, Matthew H Taylor, Manish R Patel, Deborah J Wong, Anja H Loos

Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication.
Salvatore Siena, Robert Glynne-Jones, Antoine Adenis, Josef Thaler, Peter Preusser, Anja H Loos

Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
Carsten Bokemeyer, Igor Bondarenko, Anatoly Makhson, Joerg T Hartmann, Jorge Aparicio, Anja H Loos

J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study.
Hansjochen Wilke, Robert Glynne-Jones, Josef Thaler, Antoine Adenis, Peter Preusser, Anja H Loos

J Clin Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer consequences of the Chernobyl accident: 20 years on.
Elisabeth Cardis, Geoffrey Howe, Elaine Ron, Vladimir Bebeshko, Tetyana Bogdanova, Anja Loos

J Radiol Prot· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological quality of carbonated drinking water produced with in-home carbonation systems.
Wolfgang Kohnen, Susanne Teske-Keiser, Heinz-Georg Meyer, Anja H Loos, Michael Pietsch

Int J Hyg Environ Health· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe.
Freddie Bray, Anja H Loos, Mariet Oostindier, Elisabete Weiderpass

Int J Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.
Freddie Bray, Anja Helena Loos, Sandro Tognazzo, Carlo La Vecchia

Int J Cancer· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
Freddie Bray, Anja H Loos, Peter McCarron, Elizabete Weiderpass, Mark Arbyn

Cancer Epidemiol Biomarkers Prev· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Ali Asghar Peivandi, Manfred Dahm, Ulrich Tim Opfermann, Dirk Peetz, Felix Doerr, Anja Loos

Herz· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis